AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DAXOR CORP

Regulatory Filings Feb 28, 2017

Preview not available for this file type.

Download Source File

NT-NSAR 1 nt-nsar.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

SEC File Number

811-22684

NOTIFICATION OF LATE FILING

(Check One) : [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [X] Form N-SAR [ ] Form N-CSR

For Period Ended: December 31, 2016

[ ] Transition Report on Form 10-K

[ ] Transition Report on Form 20-F

[ ] Transition Report on Form 11-K

[ ] Transition Report on Form 10-Q

[ ] Transition Report on Form N-SAR

For the Transition Period Ended: ______

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

Daxor Corporation

Field: Rule-Page

Field: /Rule-Page

Full Name of Registrant

Field: Rule-Page

Field: /Rule-Page

Former Name if Applicable

350 Fifth Avenue, Suite 4740

Field: Rule-Page

Field: /Rule-Page

Address of Principal Executive Office (Street and Number)

New York, New York 10118

Field: Rule-Page

Field: /Rule-Page

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

| | (a) | The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| --- | --- | --- |
| [X] | (b) | The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR,
or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be
filed on or before the fifth calendar day following the prescribed due date; and |
| | (c) | The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

PART III — NARRATIVE

State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

The Registrant is unable to complete its Form N-SAR and transmit its annual report to shareholders for the twelve months period ended December 31, 2016 within the prescribed time period due to the inability of the registrant to obtain all the required and relevant data. The registrant expects to file its Form N-SAR on March 16, 2017.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

| Michael
Feldschuh | 212 | 330-8505 |
| --- | --- | --- |
| (Name) | (Area
Code) | (Telephone
Number) |

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

[X] Yes [ ] No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

[ ] Yes [X] No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Field: Page; Sequence: 2

Field: /Page

Daxor Corporation

Field: Rule-Page

Field: /Rule-Page

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

| Date: | /s/
Michael Feldschuh |
| --- | --- |
| Name: | Michael
Feldschuh |
| Title: | President
and Chief Executive Officer |

Field: Page; Sequence: 3

Field: /Page

Talk to a Data Expert

Have a question? We'll get back to you promptly.